Category Archives: HIV care & treatment

Egrifta distribution resumes in the US to replenish supply chain


Note from Project Inform: For patients who had their Egrifta prescription refills interrupted, it is likely you/your provider will need to fill out initial paperwork to re-start Egrifta, because this is a new company that’s responsible for its distribution. Other than that, there shouldn’t be any…Read More

NIH-led scientists discover HIV antibody that binds to novel target on virus


WHAT: An NIH-led team of scientists has discovered a new vulnerability in the armor of HIV that a vaccine, other preventive regimen or treatment could exploit. The site straddles two proteins, gp41 and gp120, that jut out of the virus and augments other known places where…Read More

HIV medical organizations challenge insurer restrictions to HCV treatment


WASHINGTON, DC – The American Academy of HIV Medicine (AAHIVM) and the HIV Medicine Association (HIVMA), the two largest professional associations representing HIV clinicians in the U.S., are challenging new health plan cost control policies barring many qualified HIV care providers from prescribing certain medications that treat…Read More

The ACE TA Center: Affordable Care Enrollment for the Ryan White Community


If you or your agency is looking for support around helping clients gain access to health insurance, the ACE TA Center may be able to help. “The goal of the ACE TA Center is to help RWHAP grantees and providers enroll diverse clients, especially people of…Read More

Project Inform remembers 40,000 Americans lost to overdose annually


In recognition of International Overdose Awareness Day, which falls on August 31, Project Inform remembers the 40,000 Americans lost to overdose each year and expresses our commitment to working with our partners, like the Harm Reduction Coalition (HRC) and the National Alliance of State and Territorial…Read More

Another full-regimen HIV pill enters the market: Triumeq


Convenient options for treating HIV infection got a boost today as the new all-in-one pill called Triumeq was approved by the FDA. Triumeq is a full HIV regimen made up of the three drugs dolutegravir (Tivicay), abacavir (Ziagen) and lamivudine (Epivir). Dolutegravir is an integrase inhibitor…Read More

Project Inform meets with Douglas Brooks, Director of National AIDS Policy


Upon entering office, President Obama committed to restoring a vigorous Office of National AIDS Policy (ONAP) within the White House to oversee and coordinate the response of the federal government to the epidemic.   He also committed to developing the nation’s first comprehensive strategy for further controlling…Read More